- Market Capitalization, $K 123,679,472
- Shares Outstanding, K 2,504,140
- Annual Sales, $ 42,147 M
- Annual Income, $ 3,256 M
- 60-Month Beta 0.55
- Price/Sales 2.98
- Price/Cash Flow 7.38
- Price/Book 1.76
|Period||Period Low||Period High||Performance|
| || |
+3.10 (+6.71%)since 12/15/20
| || |
-0.57 (-1.14%)since 10/15/20
| || |
-1.86 (-3.63%)since 01/15/20
The Zacks Analyst Blog Highlights: Apple, Mastercard, Sanofi, Comcast and Altria Group
Top Stock Reports for Apple, Mastercard & Sanofi
Lexicon (LXRX) announces that data from two late-stage studies on its type II diabetes candidate, sotagliflozin, can support a regulatory approval application.
Lilly's (LLY) candidate, donanemab shows slowing of cognitive decline in Alzheimer's disease patients. Novartis (NVS) and Sanofi (SNY) announce M&A deals.
Esperion (ESPR) reports fourth-quarter preliminary results and provides guidance for operating expense in 2021. The company in-licenses oral PCSK9 inhibitor program.
MISGAV, , /PRNewswire/ -- ("Biond" or the "Company"), a privately-held biopharmaceutical company, developing novel immunotherapies for cancer and a platform enabling the intracellular delivery of biologics,...
Sanofi's (SNY) potential acquisition of Kymab, a private biotech, is set to strengthen its presence in immunology.
--HIV vaccine program to accelerate human validation of novel vaccination strategies
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Corinne Le Goff, Pharm.D., MBA, will join Moderna as Chief Commercial...
Lexicon (LXRX) initiates dosing in a mid-stage study on LX9211 for the treatment of post-herpetic neuralgia.
|Advisorshares Doubleline Value Equity ETF|
|Pharmaceutical Vaneck ETF|
|Total Intl Stock Ishares Core MSCI ETF|
|Intl Devd Markets Ishares Core MSCI ETF|
|Avantis International Equity ETF|
|3rd Resistance Point||50.74|
|2nd Resistance Point||50.22|
|1st Resistance Point||49.80|
|1st Support Level||48.86|
|2nd Support Level||48.34|
|3rd Support Level||47.92|